NBY
NovaBay Pharmaceuticals Inc
NYSE MKT: NBY · HEALTHCARE · BIOTECHNOLOGY
$1.95
+22.64% today
Updated 2026-04-02
Market cap
$51.92M
P/E ratio
—
P/S ratio
0.16x
EPS (TTM)
$-28.50
Dividend yield
—
52W range
$1 – $100
Volume
1.3M
NovaBay Pharmaceuticals Inc (NBY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.53M | $5.91M | $6.72M | $15.68M | $9.75M | $11.02M | $6.95M | $3.48M | $1.05M | $4.38M | $11.90M | $18.23M | $12.51M | $6.60M | $9.93M | $10.20M | $14.40M | $10.46M | $9.78M | $0.00 |
| Revenue growth (YoY) | — | +285.7% | +13.7% | +133.3% | -37.8% | +13.0% | -37.0% | -49.9% | -69.7% | +315.7% | +171.6% | +53.2% | -31.4% | -47.2% | +50.5% | +2.7% | +41.2% | -27.4% | -6.4% | -100.0% |
| Cost of revenue | $6.99M | $11.61M | $14.93M | $12.57M | $13.84M | $14.91M | $8000.00 | $162000.00 | $486000.00 | $1.26M | $2.46M | $2.78M | $1.50M | $1.74M | $3.97M | $3.69M | $6.62M | $4.37M | $3.30M | $140000.00 |
| Gross profit | $1.53M | $5.91M | $6.72M | $15.68M | $9.75M | $11.02M | $6.94M | $3.31M | $568000.00 | $3.12M | $9.43M | $15.45M | $11.01M | $4.86M | $5.96M | $6.51M | $7.78M | $6.08M | $6.48M | $-140000.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.9% | 95.3% | 53.9% | 71.2% | 79.3% | 84.7% | 88.0% | 73.7% | 60.0% | 63.8% | 54.0% | 58.2% | 66.3% | — |
| R&D | $4.09M | $7.42M | $9.60M | $7.34M | $8.62M | $9.91M | $9.28M | $12.46M | $9.51M | $6.04M | $1.37M | $410000.00 | $259000.00 | $184000.00 | $285000.00 | $44000.00 | $174000.00 | $34000.00 | $42000.00 | — |
| SG&A | — | $4.37M | $5.64M | $5.61M | $5.65M | $5.43M | $5.98M | $6.34M | $6.24M | $8.01M | $7.24M | $8.64M | $5.83M | $5.31M | $5.93M | $7.24M | $7.49M | $5.45M | $7.38M | $7.58M |
| Operating income | $-5.53M | $-5.88M | $-8.51M | $2.74M | $-4.52M | $-4.32M | $-8.31M | $-15.49M | $-16.88M | $-21.01M | $-10.98M | $-7.31M | $-7.87M | $-9.40M | $-6.43M | $-8.86M | $-14.42M | $-4.10M | $-5.84M | $-7.58M |
| Operating margin | -360.5% | -99.4% | -126.6% | 17.5% | -46.3% | -39.2% | -119.6% | -445.4% | -1601.3% | -479.7% | -92.3% | -40.1% | -62.9% | -142.4% | -64.7% | -86.8% | -100.1% | -39.2% | -59.7% | — |
| EBITDA | $-5.45M | $-5.21M | $-8.60M | $3.15M | $-4.09M | $-3.90M | $-7.97M | $-15.17M | $-16.67M | $-20.97M | $-10.87M | $-7.22M | $-7.61M | $-9.34M | $-6.38M | $-8.74M | $-7.20M | $-4.09M | $-5.92M | $-7.45M |
| EBITDA margin | -355.6% | -88.0% | -128.0% | 20.1% | -41.9% | -35.4% | -114.7% | -436.4% | -1581.8% | -478.7% | -91.4% | -39.6% | -60.8% | -141.5% | -64.2% | -85.7% | -50.0% | -39.2% | -60.6% | — |
| EBIT | $-5.53M | $-5.39M | $-8.91M | $2.78M | $-4.52M | $-4.32M | $-8.31M | $-15.49M | $-16.90M | $-21.14M | $-10.98M | $-7.31M | $-7.87M | $-9.40M | $-6.43M | $-8.86M | $-7.68M | $-4.45M | $-6.31M | $-7.58M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.05M | $129179.00 | $3.04M | $3.81M | $1.69M | $904000.00 | $277000.00 |
| Income tax | $-240000.00 | $12000.00 | $2000.00 | $7000.00 | $50000.00 | $2000.00 | $2000.00 | $2000.00 | $2000.00 | $12000.00 | $2000.00 | $3000.00 | $4000.00 | $6000.00 | $5000.00 | $-4.62M | $-3.81M | $35105.00 | — | — |
| Effective tax rate | 4.3% | -0.2% | -0.0% | 0.3% | -1.2% | -0.0% | -0.0% | -0.0% | -0.0% | -0.1% | -0.0% | -0.0% | -0.1% | -0.1% | -0.0% | 44.2% | 26.4% | -0.4% | 0.0% | 0.0% |
| Net income | $-5.29M | $-5.40M | $-8.11M | $2.70M | $-4.31M | $-5.08M | $-7.03M | $-16.04M | $-15.19M | $-18.97M | $-13.15M | $-7.40M | $-6.54M | $-9.66M | $-11.04M | $-5.82M | $-10.61M | $-9.64M | $-7.22M | $-22.14M |
| Net income growth (YoY) | — | -2.2% | -50.3% | +133.2% | -259.7% | -18.0% | -38.2% | -128.3% | +5.3% | -24.9% | +30.7% | +43.7% | +11.6% | -47.6% | -14.3% | +47.2% | -82.1% | +9.1% | +25.1% | -206.5% |
| Profit margin | -344.8% | -91.3% | -120.7% | 17.2% | -44.2% | -46.1% | -101.2% | -461.4% | -1441.6% | -433.1% | -110.5% | -40.6% | -52.3% | -146.4% | -111.1% | -57.1% | -73.6% | -92.2% | -73.8% | — |